LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung

Nektarios Barabutis, Vaishali Handa, Christiana Dimitropoulou, Ruslan Rafikov, Connie Snead, Sanjiv Kumar, Atul Joshi, Gagan Thangjam, David Fulton, Stephen M. Black, Vijay Patel, John D. Catravas

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Heat shock protein 90 (Hsp90) inhibitors were initially developed as anticancer agents; however, it is becoming increasing clear that they also possess potent anti-inflammatory properties. Posttranslational modifications of Hsp90 have been reported in tumors and have been hypothesized to affect client protein- and inhibitor-binding activities. In the present study we investigated the posttranslational modification of Hsp90 in inflammation. LPS, a prototypical inflammatory agent, induced concentrationand time-dependent tyrosine (Y) phosphorylation of Hsp90α and Hsp90α in bovine pulmonary arterial and human lung microvascular endothelial cells (HLMVEC). Mass spectrometry identified Y309 as a major site of Y phosphorylation on Hsp90α (Y300 of Hsp90β). LPS-induced Hsp90 phosphorylation was prevented by the Hsp90 inhibitor 17-allyl-amino-demethoxy-geldanamycin (17-AAG) in vitro as well as in lungs from LPS-treated mice, in vivo. Furthermore, 17-AAG prevented LPS-induced pp60src activation. LPS-induced Hsp90 phosphorylation was also prevented by the pp60src inhibitor PP2. Additionally, Hsp90 phosphorylation was induced by infecting cells with a constitutively active pp60src adenovirus, whereas either a dominant-negative pp60src adenovirus or reduced expression of pp60src by a specific siRNA prevented the LPS-induced Y phosphorylation of Hsp90. Transfection of HLMVEC with the nonphosphorylatable Hsp90β Y300F mutant prevented LPS-induced Hsp90β tyrosine phosphorylation but not pp60src activation. Furthermore, the Hsp90β Y300F mutant showed a reduced ability to bind the Hsp90 client proteins eNOS and pp60src and HLMVEC transfected with the mutant exhibited reduced LPS-induced barrier dysfunction. We conclude that inflammatory stimuli cause posttranslational modifications of Hsp90 that are Hsp90-inhibitor sensitive and may be important to the proinflammatory actions of Hsp90.

Original languageEnglish (US)
Pages (from-to)L883-l893
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume304
Issue number12
DOIs
StatePublished - Jun 15 2013

Fingerprint

HSP90 Heat-Shock Proteins
Tyrosine
Endothelial Cells
Phosphorylation
Lung
Post Translational Protein Processing
Adenoviridae

Keywords

  • Endothelial cells
  • Hsp90
  • Human
  • LPS
  • Posttranslational modifications

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung. / Barabutis, Nektarios; Handa, Vaishali; Dimitropoulou, Christiana; Rafikov, Ruslan; Snead, Connie; Kumar, Sanjiv; Joshi, Atul; Thangjam, Gagan; Fulton, David; Black, Stephen M.; Patel, Vijay; Catravas, John D.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 304, No. 12, 15.06.2013, p. L883-l893.

Research output: Contribution to journalArticle

Barabutis, Nektarios ; Handa, Vaishali ; Dimitropoulou, Christiana ; Rafikov, Ruslan ; Snead, Connie ; Kumar, Sanjiv ; Joshi, Atul ; Thangjam, Gagan ; Fulton, David ; Black, Stephen M. ; Patel, Vijay ; Catravas, John D. / LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2013 ; Vol. 304, No. 12. pp. L883-l893.
@article{7939828a4d814373beefb3cba91ce9a3,
title = "LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung",
abstract = "Heat shock protein 90 (Hsp90) inhibitors were initially developed as anticancer agents; however, it is becoming increasing clear that they also possess potent anti-inflammatory properties. Posttranslational modifications of Hsp90 have been reported in tumors and have been hypothesized to affect client protein- and inhibitor-binding activities. In the present study we investigated the posttranslational modification of Hsp90 in inflammation. LPS, a prototypical inflammatory agent, induced concentrationand time-dependent tyrosine (Y) phosphorylation of Hsp90α and Hsp90α in bovine pulmonary arterial and human lung microvascular endothelial cells (HLMVEC). Mass spectrometry identified Y309 as a major site of Y phosphorylation on Hsp90α (Y300 of Hsp90β). LPS-induced Hsp90 phosphorylation was prevented by the Hsp90 inhibitor 17-allyl-amino-demethoxy-geldanamycin (17-AAG) in vitro as well as in lungs from LPS-treated mice, in vivo. Furthermore, 17-AAG prevented LPS-induced pp60src activation. LPS-induced Hsp90 phosphorylation was also prevented by the pp60src inhibitor PP2. Additionally, Hsp90 phosphorylation was induced by infecting cells with a constitutively active pp60src adenovirus, whereas either a dominant-negative pp60src adenovirus or reduced expression of pp60src by a specific siRNA prevented the LPS-induced Y phosphorylation of Hsp90. Transfection of HLMVEC with the nonphosphorylatable Hsp90β Y300F mutant prevented LPS-induced Hsp90β tyrosine phosphorylation but not pp60src activation. Furthermore, the Hsp90β Y300F mutant showed a reduced ability to bind the Hsp90 client proteins eNOS and pp60src and HLMVEC transfected with the mutant exhibited reduced LPS-induced barrier dysfunction. We conclude that inflammatory stimuli cause posttranslational modifications of Hsp90 that are Hsp90-inhibitor sensitive and may be important to the proinflammatory actions of Hsp90.",
keywords = "Endothelial cells, Hsp90, Human, LPS, Posttranslational modifications",
author = "Nektarios Barabutis and Vaishali Handa and Christiana Dimitropoulou and Ruslan Rafikov and Connie Snead and Sanjiv Kumar and Atul Joshi and Gagan Thangjam and David Fulton and Black, {Stephen M.} and Vijay Patel and Catravas, {John D.}",
year = "2013",
month = "6",
day = "15",
doi = "10.1152/ajplung.00419.2012",
language = "English (US)",
volume = "304",
pages = "L883--l893",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "12",

}

TY - JOUR

T1 - LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung

AU - Barabutis, Nektarios

AU - Handa, Vaishali

AU - Dimitropoulou, Christiana

AU - Rafikov, Ruslan

AU - Snead, Connie

AU - Kumar, Sanjiv

AU - Joshi, Atul

AU - Thangjam, Gagan

AU - Fulton, David

AU - Black, Stephen M.

AU - Patel, Vijay

AU - Catravas, John D.

PY - 2013/6/15

Y1 - 2013/6/15

N2 - Heat shock protein 90 (Hsp90) inhibitors were initially developed as anticancer agents; however, it is becoming increasing clear that they also possess potent anti-inflammatory properties. Posttranslational modifications of Hsp90 have been reported in tumors and have been hypothesized to affect client protein- and inhibitor-binding activities. In the present study we investigated the posttranslational modification of Hsp90 in inflammation. LPS, a prototypical inflammatory agent, induced concentrationand time-dependent tyrosine (Y) phosphorylation of Hsp90α and Hsp90α in bovine pulmonary arterial and human lung microvascular endothelial cells (HLMVEC). Mass spectrometry identified Y309 as a major site of Y phosphorylation on Hsp90α (Y300 of Hsp90β). LPS-induced Hsp90 phosphorylation was prevented by the Hsp90 inhibitor 17-allyl-amino-demethoxy-geldanamycin (17-AAG) in vitro as well as in lungs from LPS-treated mice, in vivo. Furthermore, 17-AAG prevented LPS-induced pp60src activation. LPS-induced Hsp90 phosphorylation was also prevented by the pp60src inhibitor PP2. Additionally, Hsp90 phosphorylation was induced by infecting cells with a constitutively active pp60src adenovirus, whereas either a dominant-negative pp60src adenovirus or reduced expression of pp60src by a specific siRNA prevented the LPS-induced Y phosphorylation of Hsp90. Transfection of HLMVEC with the nonphosphorylatable Hsp90β Y300F mutant prevented LPS-induced Hsp90β tyrosine phosphorylation but not pp60src activation. Furthermore, the Hsp90β Y300F mutant showed a reduced ability to bind the Hsp90 client proteins eNOS and pp60src and HLMVEC transfected with the mutant exhibited reduced LPS-induced barrier dysfunction. We conclude that inflammatory stimuli cause posttranslational modifications of Hsp90 that are Hsp90-inhibitor sensitive and may be important to the proinflammatory actions of Hsp90.

AB - Heat shock protein 90 (Hsp90) inhibitors were initially developed as anticancer agents; however, it is becoming increasing clear that they also possess potent anti-inflammatory properties. Posttranslational modifications of Hsp90 have been reported in tumors and have been hypothesized to affect client protein- and inhibitor-binding activities. In the present study we investigated the posttranslational modification of Hsp90 in inflammation. LPS, a prototypical inflammatory agent, induced concentrationand time-dependent tyrosine (Y) phosphorylation of Hsp90α and Hsp90α in bovine pulmonary arterial and human lung microvascular endothelial cells (HLMVEC). Mass spectrometry identified Y309 as a major site of Y phosphorylation on Hsp90α (Y300 of Hsp90β). LPS-induced Hsp90 phosphorylation was prevented by the Hsp90 inhibitor 17-allyl-amino-demethoxy-geldanamycin (17-AAG) in vitro as well as in lungs from LPS-treated mice, in vivo. Furthermore, 17-AAG prevented LPS-induced pp60src activation. LPS-induced Hsp90 phosphorylation was also prevented by the pp60src inhibitor PP2. Additionally, Hsp90 phosphorylation was induced by infecting cells with a constitutively active pp60src adenovirus, whereas either a dominant-negative pp60src adenovirus or reduced expression of pp60src by a specific siRNA prevented the LPS-induced Y phosphorylation of Hsp90. Transfection of HLMVEC with the nonphosphorylatable Hsp90β Y300F mutant prevented LPS-induced Hsp90β tyrosine phosphorylation but not pp60src activation. Furthermore, the Hsp90β Y300F mutant showed a reduced ability to bind the Hsp90 client proteins eNOS and pp60src and HLMVEC transfected with the mutant exhibited reduced LPS-induced barrier dysfunction. We conclude that inflammatory stimuli cause posttranslational modifications of Hsp90 that are Hsp90-inhibitor sensitive and may be important to the proinflammatory actions of Hsp90.

KW - Endothelial cells

KW - Hsp90

KW - Human

KW - LPS

KW - Posttranslational modifications

UR - http://www.scopus.com/inward/record.url?scp=84879160939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879160939&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00419.2012

DO - 10.1152/ajplung.00419.2012

M3 - Article

C2 - 23585225

AN - SCOPUS:84879160939

VL - 304

SP - L883-l893

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 12

ER -